Is Selective Digestive Decontamination Useful for Critically Ill Patients?

Area of Science:

• Critical Care Medicine
• Infectious Diseases
• Clinical Pharmacy

Background:

• Selective digestive decontamination (SDD) is a strategy used in critically ill patients to prevent nosocomial infections.
• It involves topical nonabsorbable antibiotics and a short course of intravenous cephalosporins.
• The goal is to prevent colonization by pathogens while preserving beneficial gut flora.

Purpose of the Study:

• To review the rationale and effects of SDD on clinical outcomes.
• To assess the impact of SDD on infections with antimicrobial-resistant microorganisms.
• To evaluate the overall benefit-risk profile of SDD in intensive care settings.

Main Methods:

• Review of existing literature and randomized trials on SDD.
• Analysis of data on clinical outcomes, mortality, and infection rates.
• Examination of resistance patterns associated with SDD use.

Main Results:

• SDD decreases the risk of nosocomial infections and reduces mortality in mechanically ventilated patients in low-resistance settings.
• Evidence suggests SDD does not increase, and may decrease, resistance rates to some antibiotics.
• Confidence in data is limited, especially in high-resistance environments.

Conclusions:

• SDD shows potential for improving outcomes in critically ill patients.
• Long-term ecological effects on antimicrobial resistance require further large-scale multinational trials.
• Current evidence does not support widespread SDD use, except in areas with very low antibiotic resistance prevalence.